<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2072-8174</journal-id>
<journal-title><![CDATA[Revista del Nacional (Itauguá)]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Nac. (Itauguá)]]></abbrev-journal-title>
<issn>2072-8174</issn>
<publisher>
<publisher-name><![CDATA[Hospital Nacional (Itauguá)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2072-81742021000100076</article-id>
<article-id pub-id-type="doi">10.18004/rdn2021.jun.01.076.087</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Características clínicas de la criptococosis cerebral en pacientes infectados por el VIH: Hospital Nacional de Paraguay años 2012 a 2020]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical characteristics of cerebral cryptococcosis in HIV-infected patients: Hospital Nacional de Paraguay years 2012 to 2020]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aveiro]]></surname>
<given-names><![CDATA[Alba Concepción]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fretes Lezcano]]></surname>
<given-names><![CDATA[Vanesa Aniana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Real Delor]]></surname>
<given-names><![CDATA[Raúl Emilio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marín Ricart]]></surname>
<given-names><![CDATA[Martha Rosa Lourdes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Centro Médico Nacional, Hospital Nacional Departamento de Medicina Interna]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Itapúa Posgrado de Medicina Interna ]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Centro Médico Nacional, Hospital Nacional Departamento de Laboratorio, Servicio Microbiología]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>13</volume>
<numero>1</numero>
<fpage>76</fpage>
<lpage>87</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2072-81742021000100076&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2072-81742021000100076&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2072-81742021000100076&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el cuadro clínico de la infección por el VIH refleja la inmunodeficiencia progresiva desde fases iniciales a veces asintomáticas hasta las finales cuando clínicamente corresponde a estadios más avanzados de inmunosupresión, con linfocitos T CD4 &lt; 100cel /µL, el síndrome de inmunodeficiencia adquirida, en el que ya aparecen las enfermedades definitorias, una de ellas la criptococosis cerebral.  Objetivos: describir las características clínicas de la criptococosis cerebral en pacientes infectados por el VIH internados en el servicio de Clínica Médica del Hospital Nacional - Itauguá, Paraguay de 2012 a 2020.  Metodología: se realizó un estudio observacional descriptivo, retrospectivo de corte transversal, en pacientes de ambos sexos mayores de 18 años.  Resultados: se estudiaron 35 pacientes, 69 % fueron varones, con mediana de edad 43 años. El 100 % se hallaba sin tratamiento antirretroviral al ingreso, 74 % no se conocían infectados por el VIH y el 26 % no tenía adherencia al tratamiento. El cuadro evolutivo en promedio fue de 20 días (2 a 90 días), el 91 % de los síntomas al ingreso fueron neurológicos, siendo el predominante la cefalea, que se presentó en forma aislada en el 28 % y el resto con otro síntoma neurológico. La carga viral promedio fue 867.464 copias/mL, la mediana del nivel CD4 34 cél/mm3 y el 100 % &lt; 150 cél/mm3. El promedio de los hallazgos del líquido cefalorraquídeo fueron glucorraquia 37 mg/dl, proteinorraquia 174 mg/dl, la celularidad 46 % &#8804; 6 cél/&#956;l, 98 % con predominio mononuclear. Todos fueron tratados con anfotericina B y de mantenimiento con fluconazol. La mediana de los días de internación fue 30 días y la mortalidad de 26 %, siendo los factores de mal pronóstico: consulta tardía, no conocidos infectados por VIH y mayor carga viral.  Conclusiones: se pudo evidenciar mayoría de los casos en pacientes varones, adultos jóvenes, en estadio sida, 100 % sin tratamiento en antirretrovirales y como factores de mal pronóstico la consulta tardía y la alta carga viral. Es válida la sospecha de concomitancia criptococosis meníngea-VIH, en pacientes con cefalea crónica aun en pacientes no conocidos infectados con VIH.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  the clinical picture of HIV infection reflects the progressive immunodeficiency from the initial phases, sometimes asymptomatic to the final, when clinically it corresponds to more advanced stages of immunosuppression, with CD4 T lymphocytes &lt;100cells / µL, the acquired immunodeficiency syndrome, in the one that already appears the defining diseases, one of them the cerebral cryptococcosis.  Objectives:  to describe the clinical characteristics of cerebral cryptococcosis in HIV-infected patients admitted to the Medical Clinic Service of the Hospital Nacional - Itauguá, Paraguay from 2012 to 2020.  Methodology:  a descriptive, retrospective, cross-sectional observational study was carried out in patients of both sexes older than 18 years.  Results:  35 patients were studied, 69 % were male, with a median age of 43 years. 100 % were without antiretroviral treatment upon admission, 74 % were not known to be infected with HIV, and 26 % had no adherence to treatment. The evolutionary picture on average was 20 days (2 to 90 days), 91 % of the symptoms on admission were neurological, the predominant being headache, which occurred in isolation in 28 % and the rest with another neurological symptom . The mean viral load was 867,464 copies / mL, the median CD4 level was 34 cells / mm3 and 100 % &lt;150 cells / mm3. The mean cerebrospinal fluid findings were glucorrhachia 37 mg / dl, protein sprain 174 mg / dl, cellularity 46 % &#8804; 6 cells / &#956;l, 98% predominantly mononuclear. All were treated with amphotericin B and maintenance with fluconazole. The median number of days of hospitalization was 30 days and mortality was 26 %, with poor prognosis factors being: late consultation, unknown HIV-infected patients, and higher viral load.  Conclusions:  most of the cases could be evidenced in male patients, young adults, in the AIDS stage, 100 % without antiretroviral treatment, and late consultation and high viral load as poor prognostic factors. The suspicion of meningeal cryptococcosis-HIV concomitance is valid in patients with chronic headache even in unknown patients infected with HIV.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[virus de la inmunodeficiencia humana]]></kwd>
<kwd lng="es"><![CDATA[meningitis criptocócica]]></kwd>
<kwd lng="es"><![CDATA[Cryptococcus neoformans.]]></kwd>
<kwd lng="en"><![CDATA[human immunodeficiency virus]]></kwd>
<kwd lng="en"><![CDATA[cryptococcal meningitis]]></kwd>
<kwd lng="en"><![CDATA[Cryptococcus neoformans.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mandell]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Dolin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedades infecciosas: principios y prácticas]]></source>
<year>2020</year>
<volume>2</volume>
<edition>8a</edition>
<page-range>3101-5</page-range><publisher-loc><![CDATA[Elsevier ]]></publisher-loc>
<publisher-name><![CDATA[Barcelona]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sardiñas Ponce]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualización sobre el virus de inmunodeficiencia humana y el síndrome de inmunodeficiencia adquirida]]></article-title>
<source><![CDATA[Revista Electrónica de las Ciencias Médicas en Cienfuegos]]></source>
<year>2010</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>33-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tobón Pereira]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Toro Montoya]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio del paciente con infección por VIH]]></article-title>
<source><![CDATA[Med Lab]]></source>
<year>2008</year>
<volume>14</volume>
<numero>01-02</numero>
<issue>01-02</issue>
<page-range>11-42</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cachay]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<source><![CDATA[Infección por el virus de inmunodeficiencia humana (HIV)]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roa]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Triana]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Clavijo-Prado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cárdenas]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Criptococosis cerebral: descripción de una serie de casos con presentaciones típicas y atípicas en el Hospital Universitario San José Infantil de Bogotá]]></article-title>
<source><![CDATA[Acta Neurol Colomb]]></source>
<year>2015</year>
<volume>31</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>158-66</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Danger]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Salinas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Infecciones del sistema nervioso central en pacientes con SIDA. Hospital Distrital " Pholosong&#8221;]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Johannesburgo, Sudáfrica ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The disease ecology, epidemiology, clinical manifestations, and management of emerging cryptococcus gattii complex Infections]]></article-title>
<source><![CDATA[Wilderness &amp; Environ Med]]></source>
<year>2020</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>101-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lizarazo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Linares]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De Bedout]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Agudelo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio clínico y epidemiológico de la criptococosis en Colombia: resultados de nueve años de la encuesta nacional, 1997-2005]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2007</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>94</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duque Díaz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Criptococosis meníngea y pulmonar por c. Gattii en un paciente inmunocompetente]]></article-title>
<source><![CDATA[Rev Arg Med]]></source>
<year>2020</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>138-41</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Makadzange]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[McHugh]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New approaches to the diagnosis and treatment of cryptococcal meningitis]]></article-title>
<source><![CDATA[Semin Neurol]]></source>
<year>2014</year>
<volume>34</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-60</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jarvis]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HIV-associated cryptococcal meningitis]]></article-title>
<source><![CDATA[AIDS]]></source>
<year>2007</year>
<volume>21</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>2119-29</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Firacative]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lizarazo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Illnait-Zaragozí]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Arechavala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Córdoba]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The status of cryptococcosis in latin America]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2018</year>
<volume>113</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1-23</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Messina]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Maiolo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Negroni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Arechavala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Santiso]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alternativas terapéuticas de la criptococosis meníngea. actualizaciones en sida e infectología]]></article-title>
<source><![CDATA[Buenos Aires]]></source>
<year>2015</year>
<volume>23</volume>
<numero>88</numero>
<issue>88</issue>
<page-range>25-32</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sicer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinica-Unr Com Ar]]></article-title>
<source><![CDATA[Criptococosis meningea en pacientes infectados por el VIH]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sierra Saldívar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meningitis criptocóccica Cryptococcal meningitis]]></article-title>
<source><![CDATA[Rev Nac. (Itauguá)]]></source>
<year>2013</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-43</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lizarazo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protocolo de estudio y manejo de los pacientes con criptococosis: a protocol for the study and management of patients with cryptococcosis]]></article-title>
<source><![CDATA[Infectio]]></source>
<year>2012</year>
<volume>16</volume>
<numero>^sSupl 3</numero>
<issue>^sSupl 3</issue>
<supplement>Supl 3</supplement>
<page-range>123-5</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sloan]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Parris]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cryptococcal meningitis: Epidemiology and therapeutic options]]></article-title>
<source><![CDATA[Clin Epidemiol]]></source>
<year>2014</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>169-82</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez Árias]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Zarco Montero]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meningeal criptococcosis: clinical and laboratory characteristics]]></article-title>
<source><![CDATA[Acta Neurol Colomb]]></source>
<year>2011</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-27</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Ranjan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of cryptococcal meningitis in HIV-infected patients: Experience from western India]]></article-title>
<source><![CDATA[Indian J Sex Transm Dis]]></source>
<year>2010</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-6</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sloan]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Parris]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meningitis criptocócica: epidemiología y opciones terapéuticas]]></article-title>
<source><![CDATA[Clin Epidemiol]]></source>
<year>2014</year>
<volume>6</volume>
<page-range>169-82</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cangelosi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[De Carolis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Trombetta]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wainstein]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Criptococosis meníngea asociada al SIDA. Análisis de los pacientes varones HIV (+) con criptococosis meníngea internados en la Sala 11 del Hospital Francisco J Muñiz]]></article-title>
<source><![CDATA[Rev Asoc Med Argent]]></source>
<year>2009</year>
<volume>122</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>25-30</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Concha-Velasco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[González-Lagos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Seas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bustamante]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2017</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-12</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
